Diagnosis of CSU

Return to Enrollment Page

OVERVIEW

This module covers CSU diagnosis guidelines, including differentiation from other disorders and appropriate use of laboratory tests and imaging. This module also addresses CSU endotypes and biomarkers for individualizing diagnostic strategies and predicting therapy response.

FACULTY

Anil Nanda, MD, FAAAAI, FACAAI, FACP

Asthma and Allergy Center, Lewisville and Flower Mound, Texas
Adjunct Professor of Medicine, Division of Allergy and Immunology,
University of Texas Southwestern Medical Center

Anil Nanda, MD is in solo community-based private practice in Allergy and Immunology in the Dallas-Fort Worth Metroplex area.  He is also Adjunct Professor of Medicine in the Division of Allergy and Immunology at the University of Texas Southwestern Medical Center in Dallas.  He is involved in both local and national allergy organizations, including being the Immediate Past President of the Texas Allergy, Asthma, and Immunology Society.  He is also very involved in the American Academy of Allergy, Asthma, and Immunology (AAAAI), the American College of Allergy, Asthma, and Immunology (ACAAI), and the American Board of Allergy and Immunology (ABAI).

LEARNING OBJECTIVES

1.
APPLY evidence-based diagnostic guidelines, including appropriate use of laboratory tests and imaging, to optimize the diagnostic workup for patients with CSU
2.
INTEGRATE knowledge of CSU endotypes and validated and emerging biomarkers, including total serum IgE levels, to individualize treatment strategies and predict response to targeted therapies